Neurological complications in renal failure: a review

被引:248
作者
Brouns, R
De Deyn, PP [1 ]
机构
[1] Middleheim Gen Hosp, Dept Neurol & Memory Clin, Antwerp, Belgium
[2] Univ Antwerp, Born Bunge Fdn, Neurochem Lab, B-2610 Antwerp, Belgium
关键词
renal failure; uremia; dialysis; renal transplantation; encephalopathy; neuropathy; myopathy;
D O I
10.1016/j.clineuro.2004.07.012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurological complications whether due to the uremic state or its treatment, contribute largely to the morbidity and mortality in patients with renal failure. Despite continuous therapeutic advances, many neurological complications of uremia, like uremic encephalopathy, atherosclerosis, neuropathy and myopathy fail to fully respond to dialysis. Moreover, dialytic therapy or kidney transplantation may even induce neurological complications. Dialysis can directly or indirectly be associated with dialysis dementia, dysequilibrium syndrome, aggravation of atherosclerosis, cerebrovascular accidents due to Ultrafiltration-related arterial hypotension, hypertensive encephalopathy, Wernicke's encephalopathy, hemorrhagic stroke, subdural hematoma, osmotic myelinolysis, opportunistic infections, intracranial hypertension and mononeuropathy. Renal transplantation itself can give rise to acute femoral neuropathy, rejection encephalopathy and neuropathy in graft versus host disease. The use of immunosuppressive drugs after renal transplantation can cause encephalopathy, movement disorders, opportunistic infections, neoplasms, myopathy and progression of atherosclerosis. We address the clinical, pathophysiological and therapeutical aspects of both central and peripheral nervous system complications in uremia. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 220 条
[91]   NON SURGICAL-TREATMENT OF SUBDURAL-HEMATOMA IN A HEMODIALYSIS PATIENT [J].
INZELBERG, R ;
NEUFELD, MY ;
REIDER, I ;
GARI, P .
CLINICAL NEUROLOGY AND NEUROSURGERY, 1989, 91 (01) :85-89
[92]   CEREBELLAR FORM OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT WITH CHRONIC-RENAL-FAILURE [J].
IRIE, T ;
KASAI, M ;
ABE, N ;
SETO, K ;
NAOHARA, T ;
KAWAMURA, K ;
HIGA, T ;
SANO, K ;
TAKAHASHI, H ;
NAGASHIMA, K .
INTERNAL MEDICINE, 1992, 31 (02) :218-223
[93]   Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis [J].
Iseki, K ;
Fukiyama, K .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (11) :1808-1813
[94]   EVIDENCE FOR HIGH-RISK OF CEREBRAL-HEMORRHAGE IN CHRONIC DIALYSIS PATIENTS [J].
ISEKI, K ;
KINJO, K ;
KIMURA, Y ;
OSAWA, A ;
FUKIYAMA, K .
KIDNEY INTERNATIONAL, 1993, 44 (05) :1086-1090
[95]   Predictors of stroke in patients receiving chronic hemodialysis [J].
Iseki, K ;
Fukiyama, K .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1672-1675
[96]   The bleeding risk in chronic haemodialysis: Preventive strategies in high-risk patients [J].
Janssen, MJFM ;
vanderMeulen, J .
NETHERLANDS JOURNAL OF MEDICINE, 1996, 48 (05) :198-207
[97]   An overview of levodopa in the management of restless legs syndrome in a dialysis population: Pharmacokinetics, clinical trials, and complications of therapy [J].
Janzen, L ;
Rich, JA ;
Vercaigne, LM .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (01) :86-92
[98]  
Joy M S, 1997, ANNA J, V24, P686
[99]  
Jungers P, 1997, MINER ELECTROL METAB, V23, P170
[100]  
Jungers P, 2003, NEPHROLOGIE, V24, P79